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ORIGINAL ARTICLE
PREPARE: the prevalence of perioperative anaemia and
need for patient blood management in elective
orthopaedic surgery
A multicentre, observational study
Sigismond Lasocki, Ru¨diger Krauspe, Christian von Heymann, Anna Mezzacasa, Suki Chainey and
Donat R. Spahn
BACKGROUND Patient blood management (PBM) can pre-
vent preoperative anaemia, but little is known about practice
in Europe.
OBJECTIVE To assess the pre and postoperative prevalence
and perioperative management of anaemia in patients under-
going elective orthopaedic surgery in Europe.
DESIGN An observational study; data were collected from
patient records via electronic case report forms.
SETTING Seventeen centres in six European countries.
Centres were stratified according to whether they had a
PBM programme or not.
PATIENTS One thousand five hundred and thirty-four
patients undergoing major elective hip, knee or spine surgery
[49.9% hip, 37.2% knee, 13.0% spine; age 64.0 years
(range 18 to 80), 61.3% female].
MAIN OUTCOME MEASURES Prevalence of preoperative
(primary endpoint) and postoperative anaemia [haemoglobin
(Hb) <13 g dl1 (male), Hb <12 g dl1 (female)], periopera-
tive anaemia management, time to first blood transfusion and
number of transfused units. Data are shown as mean (SD) or
median (interquartile range).
RESULTS Anaemia prevalence increased from 14.1% pre-
operatively to 85.8% postoperatively. Mean Hb decrease
was 1.9 (1.5) and 3.0 (1.3) g dl1 in preoperatively anaemic
and nonanaemic patients, respectively (P<0.001). In PBM
(n¼7) vs. non-PBM centres, preoperative anaemia was less
frequent (8.0 vs. 18.5%; P<0.001) and iron status was
assessed more frequently (ferritin 11.0 vs. 2.6%, transferrin
saturation 11.0 vs. 0.1%; P<0.001). Perioperative anaemia
correction (mainly transfusion) was given to 34.3%. Intrao-
peratively, 14.8% of preoperatively anaemic and 2.8% of
nonanaemic patients received transfusions [units per patient:
2.4 (1.5) and 2.2 (1.4), median time to first intraoperative
transfusion: 130 (88, 158) vs. 179 (135, 256) min;
P<0.001]. Postoperative complications were more frequent
in preoperatively anaemic vs. nonanaemic patients (36.9 vs.
22.2%; P¼0.009).
CONCLUSIONMost patients who underwent elective ortho-
paedic surgery had normal preoperative Hb levels but
became anaemic after the procedure. Those who were
anaemic prior to surgery had an increased intraoperative
transfusion risk and postoperative complication rate. PBM
measures such as iron status assessment and strategies to
avoid transfusion are still underused in Europe.
Published online 6 January 2015
Introduction
Preoperative anaemia is a common condition among
patients undergoing elective surgery.1–3 Depending on
the cohort under investigation, the reported prevalences
reach up to 75%4 and in orthopaedic surgery range from
7 to 35%.5,6 Preoperative anaemia is associated with an
increased risk of postoperative morbidity1,7–10 and
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mortality1,3,11–13 as well as prolonged hospital stay.3,8,13
In addition, preoperatively anaemic patients are more
likely to receive perioperative red blood cell (RBC)
transfusions than nonanaemic patients.4,9,11,14 Hip and
knee arthroplasties are among the surgical procedures
most commonly associated with RBC transfusions.2
Analyses of large numbers of surgical patients showed a
dose-dependent association between RBC transfusion
and adverse outcomes such as increased mortality, mor-
bidity and sepsis.15–17 A Cochrane review of 19 random-
ised controlled studies comparing restrictive vs. liberal
transfusion strategies in 6264 patients showed that the
restricted use of RBC transfusions had no adverse influ-
ence on functional recovery or length of hospital stay.18
Restrictive transfusion strategies were associated with a
statistically significant reduction in hospital mortality and
a numerical reduction in 30-day mortality that was close
to being statistically significant. Interestingly, one trial in
critically ill patients showed a significant association
between restricted transfusion and lower mortality rates
among subgroups with less severe conditions (APACHE
II score 20) and lower age (<55 years).19 Overall, the
available data suggest that rather than being a first-line
anaemia treatment, RBC transfusions should be the last
resort.20,21 An approach that is intended to reduce RBC
transfusion is called patient blood management (PBM)
and is based on three pillars: correction of preoperative
anaemia, reduction of perioperative blood loss and mana-
ging iron status.2,21,22
The implementation of PBM has resulted in better
postsurgical outcome and considerable financial sav-
ings.23–26 Recently, an expert panel, and the European
Society of Anaesthesiology, have both underscored the
need for preoperative evaluation and treatment of anae-
mia.23,27 The need to implement PBM is also being
increasingly recognised by clinicians; yet little is known
about its penetration into European centres.28 This
observational study assessed the pre and postoperative
prevalence and management of anaemia in patients
undergoing elective orthopaedic surgery in Europe.
Materials and methods
Study design and patients
This study was designed as an observational, multicentre
study across six European countries. According to local
legislation, the study protocol, any protocol amendments
and the patient consent form were submitted to institu-
tional review boards and ethics committees for review
and approval. The study was conducted in compliance
with the International Conference on Harmonisation of
Good Clinical Practice and all applicable local and
national guidelines and regulations. From November
2010 to March 2011, trained medical staff collected
anonymised data on patient and treatment character-
istics, haematological and laboratory test results, as well
as treatment outcomes and complications from patient
records via electronic case report forms. All collected data
were subject to a plausibility and quality check. Entries
that did not pass the plausibility and quality check were
verified by phone interviews.
Up to 100 patients per centre, who consecutively com-
pleted elective orthopaedic hip, knee or spine surgery
between 1 January 2010 and 1 July 2010, were included in
reverse chronological order of the date of completing the
surgical procedure. Eligible patients were 18 to 80 years
of age, had a preoperative assessment within 1 day to 6
weeks prior to surgery, at least one pre and one post-
operative haemoglobin (Hb) level (maximum 4 weeks
after surgery) available and provided written informed
consent if required by local regulations. Patients would
have been excluded from participation if surgery was an
emergency (no time for preoperative anaemia manage-
ment), if the procedure was outside the scope of this
study, if they were pregnant at the time of surgery and if
there was a history of major surgical intervention within 4
weeks prior to the elective orthopaedic procedure.
Participation did not require any additional visits or assess-
ments. The administration of RBC transfusion followed
institutional policies. Centres with an institutional, pre-
operative erythropoietin or iron treatment protocol to treat
or prevent preoperative anaemia were considered as a
PBM centre. Use of antifibrinolytics was not recorded.
Objectives
Primary endpoint was the prevalence of preoperative
anaemia according to the WHO criteria [Hb <13 g dl1
(male), Hb <12 g dl1 (female)] in patients undergoing
elective orthopaedic surgery. Secondary endpoints were
patient outcomes such as prevalence of postoperative
anaemia, transfused RBC volume and time to the first
RBC transfusion (exclusive of the use of cell saver blood),
length of stay (LOS) as well as perioperative anaemia
treatment regimens used. In addition, the incidence of
postoperative complications such as deep vein thrombosis,
pulmonary embolism, bleeding, myocardial infarction/
ischaemia, arrhythmia, stroke, hypotension, urinary tract
infection, renal failure, wound infection, sepsis and labora-
tory abnormalities (other than electrolyte disturbances)
were recorded using site-specific definitions. Adverse drug
reactions and serious adverse events were not recorded.
Blood loss was calculated from pre and postoperative
haematocrit (HCT) values, intraoperatively administered
transfusion volume (VTx in litres) and estimated blood
volume according to the following formula:29
BL ¼ 2  ðBV  HCTpre  BV  HCTpost þ VTx
 HCTTxÞ  ðHCTpre þ HCTpostÞ1
BV¼ aþbpreop-weight (kg) 1000–1; (for males a¼ 1530
and b¼ 41, for females a¼ 864 and b¼ 47.9).
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Statistical methods
The proposed sample size of 1100 to 1500 patients was
based on assumptions30 about minimum differences
found between preoperatively anaemic and nonanaemic
patients, with a power of more than 90% and two-sided
alpha of 5%. On the basis of the results of a systematic
review,2 minimum detectable differences for patients
transfused, the number of RBC units given and LOS
was set to 9.9%, 0.7 RBC units and 1.0 days, respectively.
Descriptive statistical analysis summarised continuous
data by mean (standard deviation, SD), median with
25 and 75% quartiles (Q1, Q3) as appropriate or minimum
and maximum values. Categorical data were summarised
by the number and percentage of individuals in each
category. Analysis of variance (ANOVA) or analysis of
covariance (ANCOVA) was used for comparison of con-
tinuous data and logistic regression was used for categ-
orical data (SAS version 9.3; SAS Inc., Cary, North
Carolina, USA). Missing data were treated as missing.
Multivariate models were conducted using age, sex,
American Society of Anesthesiologists (ASA) Physical
Status class, anaemic status, transfusion type, surgical
procedure, enrolment in a PBM centre and the inter-
action between PBM centre and transfusion type as
covariates. Only covariates remaining statistically signifi-
cant at a level of 5% (i.e. age, transfusion type and
enrolment in a PBM centre) were kept in the final model.
Normality of the distribution of the data was explored
using the Shapiro–Wilk test and by mean of distribution
plots. Sensitivity analyses were conducted by excluding
extreme values and applying log-transformation in order
to confirm the results of the main analysis.
Results
Patient characteristics
Data from all 1534 screened patient records who under-
went elective orthopaedic surgery of the hip (765, 49.9%),
knee (570, 37.2%) or spine (199, 13.0%) in 17 centres in
six countries (Austria, France, Germany, The Nether-
lands, Spain and UK) were collected and analysed
(Table 1). Mean age of patients was 64.0 years and 938
(61.3%) were female. Baseline (preoperative) SBP and
DBP were comparable for preoperatively anaemic and
nonanaemic patients. Seven (41%) of the 17 centres that
enrolled 635 (41.4%) patients were considered as PBM
centres.
Anaemia prevalence
Prior to surgery, 217 (14.1%) patients were anaemic
(Fig. 1) and this proportion increased to 1315 (85.8%)
postoperatively. The prevalence of preoperative anaemia
was comparable in patients for hip and knee surgery (12.9
and 13.2%, respectively) but higher in patients under-
going surgery of the spine (21.6%; P¼ 0.001 vs. hip and
knee combined). No patient had a preoperative Hb level
less than 8 g dl1. Postoperatively, the prevalence of Hb
less than 8 g dl1 was 13.9% among preoperatively anae-
mic and 2.1% among nonanaemic preoperative patients
(P< 0.001) (overall 3.7%). The median time between the
last preoperative Hb assessment and surgery was 1 day
(1 to 15) for preoperatively anaemic and 7 days (1 to 25)
for nonanaemic preoperative patients (P< 0.001).
Postoperatively, 83.8% of nonanaemic preoperative
patients became anaemic and 97.7% of preoperatively
anaemic patients remained anaemic (P< 0.001). In
PBM centres, the prevalence of preoperative anaemia
was lower than in non-PBM centres (8.0 vs. 18.5%;
P< 0.001), whereas the prevalence of postoperative anae-
mia was similar (84.3 vs. 86.8%; P¼ 0.249). The preva-
lence of postoperative Hb levels less than 8 g dl1 was
lower in PBM than in non-PBM centres (overall 1.4 vs.
5.3%, P< 0.001; preoperatively anaemic patients 17.0 vs.
3.9%, P< 0.019).
Mean fall in Hb was larger in nonanaemic preoperative
patients [3.0 (1.3) g dl1] than in preoperatively anae-
mic patients [1.9 (1.5) g dl1; P< 0.001; adjusted for
procedure and sex]. Overall, mean Hb levels decreased
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Table 1 Patient baseline characteristics
All
Type of surgery
Hip Knee Spine
Number of patients, n (%) 1534 (100) 765 (49.9) 570 (37.2) 199 (13.0)
Age (years) 64.012.3 63.712.3 67.18.9 56.016.2
female, % 61.3 58.4 67.2 55.8
Weight (kg) 79.716.3 78.315.5 83.316.9 74.915.9
Preoperative Hb (g dl1) 13.71.5 13.81.5 13.61.3 13.71.6
Serum ferritin (ng ml1) (tested patients, n) 106108 (93) 144166 (26) 8765 (54) 10891 (13)
Transferrin saturation (TSAT), %
(tested patients, na)
29.29.9 (71) 30.111.1 (22) 28.18.8 (39) 31.711.8 (10)
Anaesthetic risk assessment
(according to ASA classification), %
ASA 1 13.5 13.7 11.3 19.2
ASA 2 65.0 67.1 67.7 48.3
ASA 3 20.7 18.2 20.2 32.0
ASA 4 0.8 0.9 0.8 0.6
Data shown as % of all patients or meanSD; Hb, haemoglobin. a TSAT was tested in 6 (2.8%) of preoperatively anaemic and 65 (4.9%) of nonanaemic patients.
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from 13.7 (1.5) g dl1 preoperatively to 10.8 (1.6) g dl1
postoperatively (P< 0.001) without significant differ-
ences between the different procedures. Mean Hb
change was 2.9 (1.4) g dl1 overall and similar in
PBM and non-PBM centres [2.9 (1.4) and 2.8
(1.4) g dl1, respectively]. Calculated blood loss was
1.68 l (range 0.07 to 7.83 l) in nonanaemic preoperative
patients and 1.93 l (0.07 to 12.27 l) in those anaemic
preoperatively (P¼ 0.016).
Postoperative outcomes
Preoperatively anaemic patients experienced a higher
rate of postoperative complications (36.9 vs. 22.2%;
P¼ 0.009) and a longer hospital stay (11.7 9.6 vs.
8.8 5.9 days; P< 0.001) than those with no preoperative
anaemia, which is in accord with a higher rate of ASA
scores 3 to 4 among preoperatively anaemic vs. nonanae-
mic patients (35.1 and 18.4%, respectively). Multivariate
analyses after adjustment for sex, age, ASA and preo-
perative anaemia status showed that LOS is indepen-
dently associated with receipt of a RBC transfusion and
enrolment in a non-PBM centre (Table 2). Also, patients
who had received a RBC transfusion and were adjusted
for ASA and surgical procedure had a higher risk of
postoperative complications than patients without RBC
transfusions (Table 2). Overall, excluding electrolyte
disturbances, hypotension, vomiting, bleeding and urin-
ary retention, the most common postoperative compli-
cations were laboratory abnormalities (Table 3).
Assessment of iron status and inflammation
Iron status was only assessed in a small percentage
(<10%) of patients. Serum ferritin was assessed in 93
patients (6%) overall, with a higher rate in PBM vs. non-
PBM centres [n¼ 70 (11.0%) vs. n¼ 23 (2.6%);
P< 0.001]. Preoperative mean serum ferritin levels were
similar between PBM and non-PBM centres [100 (108)
vs. 124 (110) ng ml1; P¼ 0.36] and between anaemic
[n¼ 12 (5.5%)] and nonanaemic [n¼ 81 (6.2%)] patients
[104 (90) vs. 106 (111) ng ml1; P¼ 0.946]. Among non-
anaemic preoperative patients with available ferritin levels
who became anaemic after surgery, 47 (61.8%) had pre-
operative serum ferritin levels less than 100 ng ml-1, indi-
cating iron deficiency.1 Preoperative transferrin saturation
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Fig. 1
All patients
1534(100%)
Hip 765 (49.9%)
Knee 570 (37.2%)
Spine 199 (13.0%)
Preoperatively anaemic
217 (14.1%*)
Preoperatively non-anaemic
1317 (85.9%*)
Knee
75 (13.2%†)
Perioperative
treatment‡:
RBC
33 (44.0%§)
Anaemia
treatments
20 (26.7%§)
Postoperative
anaemia:
74 (98.7%§)
Spine
43 (21.6%†)
Perioperative
treatment‡:
RBC
13 (30.2%§)
Anaemia
treatments
6 (14.0%§)
Postoperative
anaemia:
39 (92.9%§)
Hip
99 (12.9%†)
Perioperative
treatment‡:
RBC
60(60.6%§)
Anaemia
treatments
32 (32.3%§)
Postoperative
anaemia:
98 (99.0%§)
Knee
495 (86.8%†)
Perioperative
treatment‡:
RBC
120 (24.2%§)
Anaemia
treatments
70 (14.1%§)
Postoperative
anaemia:
422 (85.3%§)
Spine
156 (78.4†)
Perioperative
treatment‡:
RBC
37 (23.7%§)
Anaemia
treatments
16 (10.3%§)
Postoperative
anaemia:
112 (71.8%§)
Hip
666 (87.19%†)
Perioperative
treatment‡:
RBC
165 (24.8%§)
Anaemia
treatments
89 (13.4%§)
Postoperative
anaemia:
570 (85.6%§)
Postoperatively anaemic
211 (97.7%‖)
Postoperatively anaemic
1104 (83.8%‖)
Prevalence of pre and postoperative anaemia and incidence of perioperative anaemia treatment by site of surgery (see Table 2 for split of
perioperative anaemia treatment into type of treatment and phase of administration).
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(TSAT) was almost exclusively assessed in PBM centres
[n¼ 70 (11.0%) vs. n¼ 1 (0.1%); P< 0.001]. TSAT was
lower in preoperatively anaemic [20.9 (11.3)%; n¼ 6] than
in nonanaemic patients [30.0 (9.5)%; n¼ 65; P¼ 0.031].
C-reactive protein (CRP) was assessed in 364 (27.6%) of
nonanaemic preoperative patients and 62 (28.6%) of
anaemic patients. Median CRP levels were 0.26 (0.10
to 0.51) and 0.49 (0.20 to 1.77) g l1, respectively (maxi-
mum levels 6.78 and 24.8 g l1).
Anaemia management
Perioperative anaemia was treated in 131 (60.4%) of
preoperatively anaemic and 395 (30.0%) nonanaemic
preoperative patients [P< 0.0001; overall 526 (34.3%),
Fig. 1, Table 4]. Anaemia treatment predominantly con-
sisted of RBC transfusion [267 (50.8%) allogeneic, 161
(30.6%) autologous (% of treated patients)] followed by
iron supplementation [127 (24.1%) oral, 74 (14.1%) intra-
venous iron]. The use of erythropoiesis-stimulating
agents (ESAs) was uncommon (overall 1.4% of all
patients). Allogeneic RBC transfusion and oral iron were
more frequently used for preoperative anaemia than in
patients not anaemic preoperatively (P< 0.001). The use
of autologous RBC transfusion was similar in preopera-
tively anaemic and nonanaemic patients (P¼ 0.416).
Blood from cell salvage procedures was used in 152
(9.9%) patients overall, with comparable rates among
those with allogeneic or without RBC transfusion (6.0
and 9.0%, respectively; P¼ 0.132). Among the 161
patients receiving autologous RBC transfusion, 35
(21.7%) also received cell salvage blood (P< 0.0001 vs.
patients with nonautologous RBC transfusion). The
majority of transfused patients received at least 2 RBC
units and the mean number of units per patient was
similar, although statistically different between preopera-
tively anaemic and nonanaemic patients [2.4 (1.5) vs. 2.2
(1.4) units, P< 0.001]. Median (Q1, Q3) time to first
intraoperative RBC transfusion (excluding cell saver
blood) was 130 min (88, 158) in anaemic compared with
179 min (135, 256) in nonanaemic patients (P< 0.001;
adjusted by procedure).
The percentage of patients who had received a RBC
transfusion varied considerably across participating
centres. In non-PBM centres, more patients received
allogeneic RBC transfusions than in PBM centres (21.2
vs. 11.7%; P< 0.001, Table 4), whereas the use of auto-
logous RBC transfusion was comparable (10.8 vs. 10.1%;
P¼ 0.487). Overall, patients with knee surgery had the
lowest rate of transfusion during surgery (2.1%) compared
with 4.7% and 10.6% among patients undergoing hip or
spine procedures, respectively.
Discussion
This observational study has shown that a relatively low
proportion of patients (14.1%) present with preoperative
anaemia but a very much higher proportion (85.7%)
become anaemic after elective major orthopaedic
surgery. Overall, patients experienced a mean decrease
in Hb levels of 2.9 g dl1, which probably translated into
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Table 2 Association of length of stay and postoperative complications with red blood cell transfusion and enrolment in a nonpatient blood
management centre
Multivariate analyses (adjusted for sex, age, ASA and preoperative anaemia status) mean difference [95% CI]; P
LOS associated RBC vs. no RBC transfusion 2.07 [0.58 to 3.56]; P¼0.007 (n¼1372)
LOS associated with non-PBM vs. PBM centre 1.88 [0.38 to 3.38]; P¼0.014 (n¼1372)
RBC-transfused patients (adjusted for ASA and surgical procedure) Odds ratio [95% CI]
Postoperative complications in patients with
Allogeneic vs. no RBC 3.2 [2.3 to 4.5] (n¼1381)
Autologous vs. no RBC 1.5 [1.0 to 2.3] (n¼1381)
CI, confidence interval; LOS, length of stay; PBM, patient blood management; RBC, red blood cell.
Table 3 Postoperative complications in the overall population and stratified by preoperative anaemia status and type of centre (patient blood
management vs. nonpatient blood management centre)
Type of complicationa Overall (nU1534)
Preoperative
anaemia (nU217)
No preoperative
anaemia (nU1317)
PBM
centre
(nU899)
Non-PBM
centre
(nU635)
Total 372 (24.3) 80 (36.9%) 292 (22.2%) 136 (21.4%) 236 (26.3%)
Laboratory abnormalityb 113 (7.4%) 25 (11.5%) 88 (6.7%) 6 (0.9%) 107 (11.9%)
Hypotension 71 (4.6%) 17 (7.8%) 54 (4.1%) 19 (3.0%) 52 (5.8%)
Vomiting 50 (3.3%) 9 (4.1%) 41 (3.1%) 27 (4.3%) 23 (2.6%)
Bleeding 41 (2.7%) 14 (6.5% 27 (2.1%) 21 (3.3%) 20 (2.2%)
Urinary retention 28 (1.8%) 3 (1.4) 25 (1.9%) 23 (3.6%) 5 (0.6%)
Wound infection 24 (1.6%) 8 (3.7%) 16 (1.2%) 7 (1.1%) 17 (1.9%)
Oliguria 21 (1.4%) 8 (3.7%) 13 (1.0%) 8 (1.3%) 13 (1.4%)
Confusion 17 (1.1%) 5 (2.3%) 12 (0.9%) 6 (0.9%) 11 (1.2%)
Surgical failure Repeat surgery 15 (1.0%) 6 (2.8%) 9 (0.7%) 5 (0.8%) 10 (1.1%)
Data are shown as number of patients and percentage of the respective subgroup. No statistical tests of subcategories have been performed, as the small numbers do not
permit reliable subanalyses. PBM, patient blood management. a Reported for more than 2% of any population. b Other than electrolyte disturbance.
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the high rate of postoperative anaemia. Notably, a con-
siderable proportion of patients became severely anaemic
(Hb <8 g dl1) after surgery with a higher prevalence in
non-PBM than in PBM centres, and particularly among
those who were already anaemic (17.0%). Together with
the finding that PBM measures are underused, the high
rate of postoperative anaemia underscores the need for
effective PBM that goes beyond treating preoperative
anaemia to include reducing intraoperative blood loss
and immediate postoperative anaemia, and managing
iron status.
The observed prevalence of preoperative anaemia in our
study compares with the findings in reported studies in
orthopaedic surgery (7 to 35%).5,6 The prevalence of
postoperative anaemia is also in the range reported for
hip fracture surgery (74 to 93%)2 and hip or knee arthro-
plasty (95%).31 Given the drop in Hb when comparing
pre and postoperative values, a blood loss calculation was
performed on the basis of measured haematocrit values
and administered RBC transfusion. The high calculated
blood loss values are in line with the high rate of post-
operative anaemia despite a rather low prevalence of
preoperative anaemia in this patient group.
Statistical analysis of data from the entire cohort suggests
an association between preoperative anaemia, a higher
rate of postoperative complications and also a longer
hospital stay. This association probably reflects the more
severe underlying conditions that are indicated by higher
ASA scores among the preoperatively anaemic patients.
However, the correlation between LOS, receipt of a RBC
transfusion and admission to a non-PBM centre remained
after adjustment for ASA, preoperative anaemia status
and also sex and age. The immediate pretransfusion Hb
levels have not been recorded and so we cannot verify
whether differences in transfusion rates correlate with
different Hb levels, as transfusion triggers vary across
centres. Nevertheless, these findings are in line with
previous publications7–10 and corroborate the results of
a recent study by Musallam et al.,1 which analysed data-
base entries from 227 425 patients undergoing noncardiac
surgery. In this study, perioperative transfusion in itself
was found to be associated with increased mortality and
morbidity. Furthermore, the prevalence of preoperative
anaemia was 30.4%, with anaemia being independently
and significantly associated with increased 30-day mor-
bidity. Data from our audit complement the findings by
Musallam et al.1 by providing detailed insights into the
defined subgroup of elective orthopaedic surgery
patients, additionally including data on pre, intraopera-
tive and postoperative anaemia management and assess-
ment of iron status.
Despite recommendations that were published long
before the patients in this study underwent surgery,32
the percentage assessed for iron status in the preoperative
period was very low (<10%) and consistent with iron
being underused as a treatment option. Even in PBM
centres, only a minority of patients were tested for their
ferritin levels or TSAT, suggesting the need for an
evaluation of how PBM is actually implemented in
centres claiming to be a PBM centre. Iron status assess-
ment is not expensive and could be systematically per-
formed in this high-risk population.
Lower TSAT in preoperatively anaemic patients may
indicate the presence of iron deficiency in this subgroup.
Notably, 57 patients (61.3% of tested patients) had base-
line serum ferritin levels less than 100 ng ml1 and most
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Table 4 Perioperative anaemia management by preoperative anaemia status and type of centre (patient blood management vs. nonpatient
blood management centre). More than one treatment per patient was possiblea
Patients
Patients with anaemia treatmentM (%)
total (n)
RBC transfusion
Oral iron i.v. iron ESAAutologous Allogeneic
Perioperative 1534 10.5% 17.4% 8.3% 4.8% 1.4%
Anaemica 217 10.1% 38.7% 16.6% 4.1% 3.7%
Nonanaemica 1317 10.6% 13.9% 6.9% 4.9% 1.1%
PBM centre 635 9.8% 11.3% 6.9% 5.5% 2.5%
Non-PBM centre 899 11.0% 21.7% 9.2% 4.3% 0.7%
Preoperative 1534 0.2% 0.2% 2.3% 0.8% 1.4%
Anaemica 217 0.5% 0.5% 6.0% 1.8% 3.2%
Nonanaemica 1317 0.2% 0.2% 1.7% 0.6% 1.1%
PBM centre 635 0.2% 0.2% 2.8% 1.7% 2.5%
Non-PBM centre 899 0.2% 0.2% 2.0% 0.1% 0.5%
Intraoperative 1534 8.7% 5.7% 0.0% 2.3% 0.6%
Anaemica 217 6.0% 16.1% 0.0% 1.4% 1.8%
Nonanaemica 1317 9.2% 4.0% 0.0% 2.5% 0.4%
PBM centre 635 8.3% 3.5% 0.0% 1.3% 0.6%
Non-PBM centre 899 9.0% 7.3% 0.0% 3.1% 0.5%
Postoperative 1534 1.8% 13.8% 7.6% 2.4% 0.5%
Anaemica 217 3.7% 30.9% 15.7% 0.9% 1.8%
Nonanaemica 1317 1.5% 10.9% 6.3% 2.7% 0.2%
PBM centre 635 1.4% 9.3% 5.5% 4.1% 0.2%
Non-PBM centre 899 2.1% 16.9% 9.1% 1.2% 0.7%
Mpatients could have received more than one treatment; apreoperative anaemia status i.v., intravenous; PBM, patient blood management; RBC, red blood cell.
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of them (47 patients) became anaemic postoperatively;
eight had already been anaemic preoperatively. How-
ever, we cannot evaluate the prevalence of iron
deficiency in the entire study population. Interestingly,
the average time between last Hb measurement and
surgery was more than 1 week and was longer among
nonanaemic patients. This suggests that there is time to
institute preoperative anaemia management.
Notably, even among preoperatively anaemic patients,
only a minority of patients received anaemia treatment
such as iron or ESA. Moreover, most iron-treated
patients, even those with preoperative anaemia, received
oral iron despite the known limitations of oral vs. intra-
venous (i.v.) iron.33,34
Since this study, it has been shown that pre and intrao-
perative treatment of anaemia reduces postoperative
morbidity, transfusion requirement and length of hospital
stay.23,35,36 However, considering the high estimates of
postoperative anaemia in this and other studies2,31 and
the fact that iron deficiency is a main cause of anaemia,37
appropriate iron status assessment should become part of
pre and postoperative routine anaemia evaluation
and management.
The high reliance on RBC transfusion is a concern.
Despite continuous improvement in the production
and management of RBC concentrate, there will always
be a risk of transmitting new or re-emerging blood borne
pathogens,38,39 and perioperative transfusions per se are
associated with increased morbidity and mortality even
when only a single RBC unit is administered.15,17,40 Our
statistical analysis identified RBC transfusion as an inde-
pendent risk factor of postoperative complications and
prolonged hospitalisation (Table 2). Despite adjustment
for known confounding factors, we cannot rule out that
there may be additional unidentified reasons for this.
Interestingly, around 40% of RBC transfusions were
autologous RBC concentrates. Furthermore, cell salvage
blood was used more frequently in patients who had
received autologous transfusions than in those who had
received allogeneic or no transfusion. This may reflect
institutional approaches towards blood conservation, as
reducing blood loss and use of autologous blood salvage
make up part of the second and third pillars of PBM;22,30
yet, there were not enough data to analyse for statistical
differences between centres.
Our findings indicate that PBM measures such as iron
status assessment, i.v. iron treatment and erythropoietic
stimulation are still underused in orthopaedic surgery in
Europe. As most patients in our study became anaemic
after surgery, correction of preoperative anaemia is only
one important aspect of PBM. Providing patients with
sufficient iron reserve to cope with the blood loss during
surgery (1 ml blood corresponds approximately to 0.5 mg
iron, for a 80 kg man) and addressing the impaired
utilisation of iron due to chronic disease or surgery-
associated activation of proinflammatory cytokines is
just as important.41,42 The benefits of postoperative
i.v. iron treatment have recently been shown;43 how-
ever, there appears to be a need to increase awareness
about the role of iron in the development and treatment
of anaemia, in addition to differences between oral and
i.v. iron administration that can render oral iron therapy
inadequate or ineffective.44,45
Due to the observational nature of the study, interpret-
ation of our results is limited by the absence of a reference
arm and the lack of control over the frequency and
duration of treatment or the frequency of performed
laboratory tests. Also, additional information about the
use of antifibrinolytics might have allowed a better under-
standing of the high blood loss, as these agents may have
influenced bleeding and transfusion requirement. On the
positive side, studies such as this one reflect realities of
clinical practice and show the implementation (or ignor-
ance) of treatment recommendations and clinical evi-
dence. Observational studies can provide the basis for
new hypotheses or identify patient groups that benefit
most from a certain treatment. The observed higher
blood loss in preoperatively anaemic than in nonanaemic
patients may have a purely mathematical explanation. As
blood loss is equal to the RBC loss divided by the mean
haematocrit during blood loss, the lower mean haemato-
crit during blood loss in preoperatively anaemic vs. non-
anaemic patients (0.318 vs. 0.364; P< 0.001), resulted in a
higher calculated blood loss. Mean RBC loss was similar
in preoperatively anaemic and nonanaemic patients,
respectively.
In conclusion, the results of this observational study show
that most patients who underwent elective orthopaedic
surgery had normal preoperative Hb levels but became
anaemic after the procedure. Patients were rarely tested
for their iron status and anaemia treatment was domi-
nated by RBC transfusion despite evidence of their
potential negative effects, whereas the pharmacological
treatment of anaemia was underused and recent recom-
mendations were ignored.
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